Narendra Dereddy, MD, was appointed to the Board of Directors of the Florida Birth-Related Neurological Injury Compensation Association (NICA) and will serve as the Florida representative of hospitals.
Dereddy currently serves as the medical director for neonatology, the neonatal intensive care unit, and pediatric care transformation at AdventHealth.
Created by Florida legislature in response to the malpractice insurance crisis where obstetricians were reluctant to treat high risk pregnancies, NICA is responsible for providing medically necessary help to infants affected by catastrophic birth-related neurologic injuries. The statutory organization manages state funds collected from participating physicians and hospitals to provide appropriate medical care and assistance to these infants and their families.
“As a neonatal-perinatal medicine specialist, I have cared for hundreds of infants affected by various birth related neurologic injuries and wanted to serve on the NICA board to advocate for these vulnerable infants and support preventive measures to decrease the incidence of birth-related neurologic injuries,” Dereddy said.
Dereddy attended medical school at Banaras Hindu University in India and completed his residency and fellowship at Maria Fareri Children’s Hospital at Westchester Medical Center at New York Medical College. Additionally, he is a member of the American Academy of Pediatrics.
Dereddy is one of several AdventHealth clinical leaders who have been recently appointed to a statewide post. He will serve in this position through August 2024.
12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
Blog
New Treatments for Cardiac Amyloidosis Emerging, but Timely Diagnosis Remains Essential to Improving Outcomes
In our latest Clinician’s View, Marcos Hazday, MD, FACC, director of the hypertrophic cardiomyopathy program at AdventHealth Orlando, discusses the new cardiac amyloidosis therapeutics available...
Blog
Transforming Care for Patients with Inflammatory Bowel Disease Through a Dedicated, Interdisciplinary Specialty Clinic
In our latest Clinician’s View, Dr. Seminerio shares her personal passion for improving care for patients with inflammatory bowel disease (IBD) and talks about how AdventHealth’s recently established...
